About SpinDiag
SpinDiag is a company based in Freiburg Im Breisgau (Germany) founded in 2016 by Gregor Grob Czilwik, Frank Schwemmer, Oliver Strohmeier, Daniel Mark, Dominique Kosse, and Mark Keller. SpinDiag has raised $27.69 million across 4 funding rounds from investors including European Investment Bank, Think.Health and German Accelerator. SpinDiag offers products and services including Rhonda player, Rhonda Respi disk, Rhonda SARS-CoV-2 disk, Rhonda MRSA disk, and Rhonda app. SpinDiag operates in a competitive market with competitors including Cepheid, Day Zero Diagnostics, NeuMoDx, SeLux Diagnostics and Kryptos Biotechnologies, among others.
- Headquarter Freiburg Im Breisgau, Germany
- Founders Gregor Grob Czilwik, Frank Schwemmer, Oliver Strohmeier, Daniel Mark, Dominique Kosse, Mark Keller
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spindiag Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27.69 M (USD)
in 4 rounds
-
Latest Funding Round
$14.58 M (USD), Debt – Conventional
Oct 17, 2022
-
Investors
European Investment Bank
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpinDiag
SpinDiag offers a comprehensive portfolio of products and services, including Rhonda player, Rhonda Respi disk, Rhonda SARS-CoV-2 disk, Rhonda MRSA disk, and Rhonda app.
Device for rapid point-of-care PCR testing of infectious diseases.
Disk for detecting respiratory infections via PCR technology.
Specific kit for COVID-19 detection using point-of-care PCR.
Disk for identifying MRSA infections through rapid PCR testing.
Application for managing and analyzing PCR test results.
People of SpinDiag
Unlock access to complete
Funding Insights of SpinDiag
SpinDiag has successfully raised a total of $27.69M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $14.58 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SpinDiag
SpinDiag has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include European Investment Bank, Think.Health and German Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Early-stage tech & life sciences focused VC firm investing in geographies such as Europe
|
Locked | Locked | Locked | |
|
Acceleration programs are provided to German startups internationally.
|
Locked | Locked | Locked |
Investor details for SpinDiag
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpinDiag
Investment portfolio details for SpinDiag
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpinDiag
Detailed financials for SpinDiag
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spindiag Comparisons
Peer comparison for SpinDiag
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpinDiag
SpinDiag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Day Zero Diagnostics, NeuMoDx, SeLux Diagnostics and Kryptos Biotechnologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Developer of alternatives to traditional ELISA assays
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
Detailed competitors of SpinDiag
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spindiag
Complete news archive for SpinDiag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpinDiag
SpinDiag was founded in 2016 and raised its 1st funding round 2 years after it was founded.
SpinDiag is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.
Daniel Mark is the current CEO of SpinDiag. They have also founded this company.
SpinDiag is a funded company, having raised a total of $27.69M across 4 funding rounds to date.
SpinDiag was established in 2016 as a spin-off from Hahn-Schickard in Germany. Automated point-of-care systems are developed by the company within the medical diagnostics sector. The LabDisk platform, based on centrifugal-microfluidic technology, enables PCR testing for drug-resistant pathogens directly from patient swab samples. Operations center on rapid screening solutions for healthcare applications.
SpinDiag's top competitors include Cepheid, Day Zero Diagnostics and NeuMoDx.
SpinDiag offers Rhonda player, Rhonda Respi disk, Rhonda SARS-CoV-2 disk, Rhonda MRSA disk, and Rhonda app.
SpinDiag has 3 investors. Key investors include European Investment Bank, Think.Health, and German Accelerator.